Czibere Akos (CIK 2049427) reported 4 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-10). Recent activity: Sell AKTS (4,371 shares), Sell AKTS (14,800 shares), Sell AKTS (30,829 shares), Buy AKTS (50,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-10 | Aktis Oncology, Inc. (AKTS) | Chief Medical Officer | Sell | 4,371 | $125,482 |
| 2026-07-10 | Aktis Oncology, Inc. (AKTS) | Chief Medical Officer | Sell | 14,800 | $401,484 |
| 2026-07-10 | Aktis Oncology, Inc. (AKTS) | Chief Medical Officer | Sell | 30,829 | $861,735 |
| 2026-07-10 | Aktis Oncology, Inc. (AKTS) | Chief Medical Officer | Buy | 50,000 | $247,500 |
Source: SEC Form 4 filings · as of 2026-07-10